Venrock Healthcare Capital Partners II, L.P. - Jun 22, 2022 Form 4 Insider Report for Tricida, Inc. (TCDA)

Role: 10%+ Owner
Signature: /s/ David L. Stepp, Authorized Signatory
Stock symbol: TCDA
Transactions as of: Jun 22, 2022
Transactions value $: $5,101,092
Form type: 4
Date filed: 6/24/2022, 05:51 PM
Previous filing: Jun 21, 2022
Next filing: Jun 30, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TCDA	Common Stock	Purchase	$1.56M	+143K	+2.17%	$10.90^*	6.72M	Jun 22, 2022	By Funds	F1, F2
transaction	TCDA	Common Stock	Purchase	$2.1M	+200K	+2.98%	$10.50^*	6.92M	Jun 23, 2022	By Funds	F2, F3
transaction	TCDA	Common Stock	Purchase	$1.44M	+149K	+2.15%	$9.68^*	7.07M	Jun 24, 2022	By Funds	F2, F4, F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Consists of (i) 14,833 shares purchased by Venrock Healthcare Capital Partners II, L.P. ("VHCP II"), (ii) 6,002 shares purchased by VHCP Co- Investment Holdings II, LLC ("VHCP Co-2"), (iii) 32,081 shares purchased by Venrock Healthcare Capital Partners III, L.P. ("VHCP III"), (iv) 3,201 shares purchased by VHCP Co-Investment Holdings III, LLC ("VHCP Co-3") and (v) 86,783 shares purchased by Venrock Healthcare Capital Partners EG, L.P. ("VHCP EG").
F2	VHCP Management II, LLC ("VHCPM II") is the general partner of VHCP II and the manager of VHCP Co-2. VHCP Management III, LLC ("VHCPM III") is the general partner of VHCP III and the manager of VHCP Co-3. VHCP Management EG, LLC ("VHCPM EG") is the general partner of VHCP EG. Messrs. Shah and Koh are the voting members of VHCPM II, VHCPM III and VHCPM EG. Each of VHCPM II, VHCPM III, VHCPM EG, Shah and Koh expressly disclaims beneficial ownership over all shares held by VHCP II, VHCP Co-2, VHCP III, VHCP Co-3 and VHCP EG except to the extent of its or his indirect pecuniary interest therein.
F3	Consists of (i) 20,760 shares purchased by VHCP II, (ii) 8,400 shares purchased by VHCP Co-2, (iii) 44,900 shares purchased by VHCP III, (iv) 4,480 shares purchased by VHCP Co-3 and (v) 121,460 shares purchased by VHCP EG.
F4	Consists of (i) 15,479 shares purchased by VHCP II, (ii) 6,263 shares purchased by VHCP Co-2, (iii) 33,477 shares purchased by VHCP III, (iv) 3,340 shares purchased by VHCP Co-3 and (v) 90,561 shares purchased by VHCP EG.
F5	The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.56 to $10.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.